Laboratory Medicine ›› 2023, Vol. 38 ›› Issue (6): 599-602.DOI: 10.3969/j.issn.1673-8640.2023.06.018
Previous Articles Next Articles
Received:2021-08-13
Revised:2022-06-17
Online:2023-06-30
Published:2023-08-22
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2023.06.018
| 检测系统 | FT3/（pmol/L） | FT4/（pmol/L） | TSH/（μIU/mL） | |||||
|---|---|---|---|---|---|---|---|---|
| 测定值 | 参考区间 | 测定值 | 参考区间 | 测定值 | 参考区间 | |||
| cobas e801系统 | 3.29 | 3.10~6.80 | 12.70 | 12.00~22.00 | >100.00 | 0.27~4.20 | ||
| Alinity系统 | 3.78 | 2.63~5.70 | 7.09 | 9.01~19.05 | 58.94 | 0.35~4.94 | ||
| Centaur XPT系统 | 3.52 | 2.30~6.30 | 56.22 | 10.30~24.50 | 72.36 | 0.35~5.50 | ||
| 检测系统 | FT3/（pmol/L） | FT4/（pmol/L） | TSH/（μIU/mL） | |||||
|---|---|---|---|---|---|---|---|---|
| 测定值 | 参考区间 | 测定值 | 参考区间 | 测定值 | 参考区间 | |||
| cobas e801系统 | 3.29 | 3.10~6.80 | 12.70 | 12.00~22.00 | >100.00 | 0.27~4.20 | ||
| Alinity系统 | 3.78 | 2.63~5.70 | 7.09 | 9.01~19.05 | 58.94 | 0.35~4.94 | ||
| Centaur XPT系统 | 3.52 | 2.30~6.30 | 56.22 | 10.30~24.50 | 72.36 | 0.35~5.50 | ||
| [1] |
TYLKI-SZYMASKA A, ACUNA-HIDALGO R, KRAJEWSKA-WALASEK M, et al. Thyroid hormone resistance syndrome due to mutations in the thyroid hormone receptor α gene(THRA)[J]. J Med Genet, 2015, 52(5):312-316.
DOI URL |
| [2] |
FAVRESSE J, BURLACU M C, MAITER D, et al. Interferences with thyroid function immunoassays:clinical implications and detection algorithm[J]. Endocr Rev, 2018, 39(5):830-850.
DOI URL |
| [3] |
VAN DER WATT G, HAARBURGER D, BERMAN P. Euthyroid patient with elevated serum free thyroxine[J]. Clin Chem, 2008, 54(7):1239-1241.
DOI PMID |
| [4] |
HATTORI N, ISHIHARA T, MATSUOKA N, et al. Anti-thyrotropin autoantibodies in patients with macro-thyrotropin and long-term changes in macro-thyrotropin and serum thyrotropin levels[J]. Thyroid, 2017, 27(2):138-146.
DOI PMID |
| [5] |
BENVENGA S, PINTAUDI B, VITA R, et al. Serum thyroid hormone autoantibodies in type 1 diabetes mellitus[J]. J Clin Endocrinol Metab, 2015, 100(5):1870-1878.
DOI PMID |
| [6] |
ISMAIL A A. Identifying and reducing potentially wrong immunoassay results even when plausible and "not-unreasonable"[J]. Adv Clin Chem, 2014, 66:241-294.
PMID |
| [7] |
TAKAMURA N, HAYASHIDA N, MAEDA T. Risk of coronary heart disease and mortality for adults with subclinical hypothyroidism[J]. JAMA, 2010, 304(22):2481-2482.
DOI PMID |
| [8] |
SAKATA S, MATSUDA M, OGAWA T, et al. Prevalence of thyroid hormone autoantibodies in healthy subjects[J]. Clin Endocrinol(Oxf), 1994, 41(3):365-370.
DOI URL |
| [9] |
RUGGERI R M, GALLETTI M, MANDOLFINO M G, et al. Thyroid hormone autoantibodies in primary Sjögren syndrome and rheumatoid arthritis are more prevalent than in autoimmune thyroid disease,becoming progressively more frequent in these diseases[J]. J Endocrinol Invest, 2002, 25(5):447-454.
DOI URL |
| [10] | BEATO-VÍBORA P I, ALEJO-GONZÁLEZ S. Avoiding misdiagnosis due to antibody interference with serum free thyroxin[J]. Int J Endocrinol Metab, 2016, 15(1):e37792. |
| [11] | SRICHOMKWUN P, SCHERBERG N H, JAKŠI J, et al. Diagnostic dilemma in discordant thyroid function tests due to thyroid hormone autoantibodies[J]. AACE Clin Case Rep, 2017, 3(1):e22-e25. |
| [12] |
BOLSTAD N, WARREN D J, NUSTAD K. Heterophilic antibody interference in immunometric assays[J]. Best Pract Res Clin Endocrinol Metab, 2013, 27(5):647-661.
DOI PMID |
| [13] | 李冬梅. 异嗜性抗体对甲状腺功能检测的干扰[J]. 检验医学, 2019, 34(12):1147-1149. |
| [14] |
DESPRÉS N, GRANT A M. Antibody interference in thyroid assays:a potential for clinical misinformation[J]. Clin Chem, 1998, 44(3):440-454.
DOI URL |
| [15] |
KWOK J S, CHAN I H, CHAN M H. Biotin interference on TSH and free thyroid hormone measurement[J]. Pathology, 2012, 44(3):278-280.
DOI URL |
| [16] |
VOS M J, RONDEEL J M M, MIJNHOUT G S, et al. Immunoassay interference caused by heterophilic antibodies interacting with biotin[J]. Clin Chem Lab Med, 2017, 55(6):e122-e126.
DOI URL |
| [17] | PELTIER L, MASSART C, MOINEAU M P, et al. Anti-streptavidin interferences in Roche thyroid immunoassays:a case report[J]. Clin Chem Lab Med, 2016, 54(1):e11-e14. |
| [18] |
GESSL A, BLUEML S, BIEGLMAYER C, et al. Anti-ruthenium antibodies mimic macro-TSH in electrochemiluminescent immunoassay[J]. Clin Chem Lab Med, 2014, 52(11):1589-1594.
DOI PMID |
| [19] |
FAVRESSE J, LARDINOIS B, NASSOGNE M C, et al. Anti-streptavidin antibodies mimicking heterophilic antibodies in thyroid function tests[J]. Clin Chem Lab Med, 2018, 56(7):e160-e163.
DOI URL |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
